Format

Send to

Choose Destination
J Vis Exp. 2016 Nov 16;(117). doi: 10.3791/54458.

Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification.

Author information

1
Center for Bio/Molecular Science & Engineering, Naval Research Laboratory; Department of Emergency Medicine, Indiana University of School of Medicine.
2
Center for Bio/Molecular Science & Engineering, Naval Research Laboratory.
3
Center for Bio/Molecular Science & Engineering, Naval Research Laboratory; Scott.Walper@nrl.navy.mil.

Abstract

An increasing interest in applying synthetic biology techniques to program outer membrane vesicles (OMV) are leading to some very interesting and unique applications for OMV where traditional nanoparticles are proving too difficult to synthesize. To date, all Gram-negative bacteria have been shown to produce OMV demonstrating packaging of a variety of cargo that includes small molecules, peptides, proteins and genetic material. Based on their diverse cargo, OMV are implicated in many biological processes ranging from cell-cell communication to gene transfer and delivery of virulence factors depending upon which bacteria are producing the OMV. Only recently have bacterial OMV become accessible for use across a wide range of applications through the development of techniques to control and direct packaging of recombinant proteins into OMV. This protocol describes a method for the production, purification, and use of enzyme packaged OMV providing for improved overall production of recombinant enzyme, increased vesiculation, and enhanced enzyme stability. Successful utilization of this protocol will result in the creation of a bacterial strain that simultaneously produces a recombinant protein and directs it for OMV encapsulation through creating a synthetic linkage between the recombinant protein and an outer membrane anchor protein. This protocol also details methods for isolating OMV from bacterial cultures as well as proper handling techniques and things to consider when adapting this protocol for use for other unique applications such as: pharmaceutical drug delivery, medical diagnostics, and environmental remediation.

PMID:
27911359
PMCID:
PMC5226233
[Available on 2018-11-16]
DOI:
10.3791/54458
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for MyJove Corporation Icon for IUPUI ScholarWorks
Loading ...
Support Center